FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Share Price

Certificat

DE000JK78D35

Real-time Bid/Ask 11:41:15 26/06/2024 BST
6.03 EUR / 6.53 EUR +4.84% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE
Current month+139.60%
1 month+121.85%
Date Price Change
25/06/24 5.99 -4.31%
24/06/24 6.26 +27.49%
21/06/24 4.91 -0.81%
20/06/24 4.95 +5.54%
19/06/24 4.69 -2.09%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 08:38 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK78D3
ISINDE000JK78D35
Date issued 06/05/2024
Strike 49.98 $
Maturity Unlimited
Parity 1.63 : 1
Emission price 10.06
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.84
Lowest since issue 2.25
Spread 0.5
Spread %7.66%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.15 USD
Average target price
49.93 USD
Spread / Average Target
+24.37%
Consensus